PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Topical administration of Anchusa officinalis aerial part extracts (250 and 500 mg/kg) accelerated wound healing via improvement of TGF-β1 and antioxidant levels and inhibition of TNF-α and IL-6 [PMID:40135263]
Methanolic extract and traditional hydrophobic formulations of Alkanna tinctoria root exhibited antibacterial and antibiofilm activity against MRSA and MDR-Pseudomonas aeruginosa [PMID:39765658]
Polyphenolic-rich extracts of Anchusa officinalis presented significant α-glucosidase inhibitory activity [PMID:32548486]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 38804306 (2024) — Structural and Functional Characterization of Medicinal Plants as Selective Antibodies towards Therapy of COVID-19 Symptoms. · Antibodies (Basel, Switzerland)
- 2.PMID: 35888697 (2022) — The Metabolic Profile of Anchusa officinalis L. Differs According to Its Associated Arbuscular Mycorrhizal Fungi. · Metabolites
- 3.PMID: 40002028 (2025) — Comparison of the Potential of "Green" Classical and Natural Deep Eutectic Solvents in the Production of Natural Food Colorant Extracts from the Roots of Alkanna tinctoria (L.). · Foods (Basel, Switzerland)
- 4.PMID: 32548486 (2020) — In Vitro Evaluation of Antidiabetic and Anti-Inflammatory Activities of Polyphenolic-Rich Extracts from Anchusa officinalis and Melilotus officinalis. · ACS omega
- 5.PMID: 37905985